136 related articles for article (PubMed ID: 21349912)
21. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.
Cho MC; Choi CM; Kim S; Jang S; Jang S; Park CJ; Chi HS; Peyton MJ; Lee W; Chun S; Kim SW; Min WK
Clin Chem Lab Med; 2011 Sep; 50(3):565-72. PubMed ID: 21899495
[TBL] [Abstract][Full Text] [Related]
22. EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.
Cooper WA; Yu B; Yip PY; Ng CC; Lum T; Farzin M; Trent RJ; Mercorella B; Clarkson A; Kohonen-Corish MR; Horvath LG; Kench JG; McCaughan B; Gill AJ; O'Toole SA
J Clin Pathol; 2013 Sep; 66(9):744-8. PubMed ID: 23757037
[TBL] [Abstract][Full Text] [Related]
23. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).
Sonnweber B; Dlaska M; Skvortsov S; Dirnhofer S; Schmid T; Hilbe W
J Clin Pathol; 2006 Mar; 59(3):255-9. PubMed ID: 16505275
[TBL] [Abstract][Full Text] [Related]
24. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
[TBL] [Abstract][Full Text] [Related]
25. Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients.
Otani H; Toyooka S; Soh J; Yamamoto H; Suehisa H; Kobayashi N; Gobara H; Mimura H; Kiura K; Sano Y; Kanazawa S; Date H
J Thorac Oncol; 2008 May; 3(5):472-6. PubMed ID: 18448998
[TBL] [Abstract][Full Text] [Related]
26. EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.
Hubers AJ; Heideman DA; Yatabe Y; Wood MD; Tull J; Tarón M; Molina MA; Mayo C; Bertran-Alamillo J; Herder GJ; Koning R; Sie D; Ylstra B; Meijer GA; Snijders PJ; Witte BI; Postmus PE; Smit EF; Thunnissen E
Lung Cancer; 2013 Oct; 82(1):38-43. PubMed ID: 23927883
[TBL] [Abstract][Full Text] [Related]
27. Routine implementation of EGFR mutation testing in clinical practice in Flanders: 'HERMES' project.
Janssens A; De Droogh E; Lefebure A; Kockx M; Pauwels P; Germonpre P; van Meerbeeck JP
Acta Clin Belg; 2014 Apr; 69(2):92-7. PubMed ID: 24724747
[TBL] [Abstract][Full Text] [Related]
28. Nonenriched PCR Versus Mutant-Enriched PCR in Detecting Selected Epidermal Growth Factor Receptor Gene Mutations Among Nonsmall-Cell Lung Cancer Patients.
Zaki MA; Ramadan RA; Mahmoud MI; El-Kaffash DM; Assaad RS
Genet Test Mol Biomarkers; 2015 Aug; 19(8):444-9. PubMed ID: 26043138
[TBL] [Abstract][Full Text] [Related]
29. Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer.
Kimura H; Ohira T; Uchida O; Matsubayashi J; Shimizu S; Nagao T; Ikeda N; Nishio K
Lung Cancer; 2014 Mar; 83(3):329-33. PubMed ID: 24439568
[TBL] [Abstract][Full Text] [Related]
30. A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer.
Sakamoto T; Kodani M; Takata M; Chikumi H; Nakamoto M; Nishii-Ito S; Ueda Y; Izumi H; Makino H; Touge H; Takeda K; Yamasaki A; Yanai M; Tanaka N; Igishi T; Shimizu E
Int J Oncol; 2015 Apr; 46(4):1473-80. PubMed ID: 25651992
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples.
Hlinkova K; Babal P; Berzinec P; Majer I; Mikle-Barathova Z; Piackova B; Ilencikova D
Diagn Mol Pathol; 2013 Jun; 22(2):70-5. PubMed ID: 23628817
[TBL] [Abstract][Full Text] [Related]
32. A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer.
Yi S; Zhuang Y; Zhou J; Ma H; Huang J; Wang L; Zhu W; Kang S; Guo L; Guo F
Int J Mol Med; 2014 Aug; 34(2):464-74. PubMed ID: 24891042
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor (EGFR) mutation testing, from bench to practice: a single institute experience.
Shikhrakab H; Elamin YY; O'Brien C; Gately K; Finn S; O'Byrne K; Osman N
Ir Med J; 2014; 107(7):201-4. PubMed ID: 25226713
[TBL] [Abstract][Full Text] [Related]
34. Consistent mutation status within histologically heterogeneous lung cancer lesions.
Mattsson JS; Imgenberg-Kreuz J; Edlund K; Botling J; Micke P
Histopathology; 2012 Oct; 61(4):744-8. PubMed ID: 22458769
[TBL] [Abstract][Full Text] [Related]
35. EGFR mutation detection by microfluidic technology: a validation study.
Malapelle U; Russo S; Pepe F; Sgariglia R; De Luca C; Bellevicine C; Pallante P; Troncone G
J Clin Pathol; 2013 Nov; 66(11):982-4. PubMed ID: 23794480
[TBL] [Abstract][Full Text] [Related]
36. Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.
Pasquale R; Fenizia F; Esposito Abate R; Sacco A; Esposito C; Forgione L; Rachiglio AM; Bevilacqua S; Montanino A; Franco R; Rocco G; Botti G; Denis MG; Morabito A; De Luca A; Normanno N
Pharmacogenomics; 2015; 16(10):1135-48. PubMed ID: 26249748
[TBL] [Abstract][Full Text] [Related]
37. [High-resolution melting analysis for the detection of EGFR mutations in circulating DNA of lung cancer patients].
Zhao J; Peng QX; Yang BH; Lu DR
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(10):674-8. PubMed ID: 21600173
[TBL] [Abstract][Full Text] [Related]
38. Preselection of EGFR mutations in non-small-cell lung cancer patients by immunohistochemistry: comparison with DNA-sequencing, EGFR wild-type expression, gene copy number gain and clinicopathological data.
Gaber R; Watermann I; Kugler C; Vollmer E; Perner S; Reck M; Goldmann T
Rom J Morphol Embryol; 2017; 58(4):1175-1184. PubMed ID: 29556606
[TBL] [Abstract][Full Text] [Related]
39. [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing].
Zhang HP; Ruan L; Zheng LM; Bai DY; Zhang HF; Liao YQ; Ding Y
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):28-32. PubMed ID: 23648296
[TBL] [Abstract][Full Text] [Related]
40. High resolution melting analysis for epidermal growth factor receptor mutations in formalin-fixed paraffin-embedded tissue and plasma free DNA from non-small cell lung cancer patients.
Jing CW; Wang Z; Cao HX; Ma R; Wu JZ
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6619-23. PubMed ID: 24377577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
